One of the major challenges faced by technology start-ups is proving the technology can deliver as promised. CoreBiome, an early-stage company offering microbiome analysis services, cleared that hurdle with support from CTSI and several other University entities.
Two of CoreBiome’s founders received support from the CTSI-administered Translational Product Development Fund (TPDF) to conduct critical proof-of-principle experiments. This generated data that ultimately helped lead to the company’s formation by attracting business talent, investors, and customers.
“We just recently launched our start-up, yet we’ve already attracted customers and $800,000 in seed funding,” says Daryl Gohl, PhD, R&D Lead at the University of Minnesota Genomics Center (UMGC).
“I don’t think we’d be where we are now without TPDF support, which enabled us to prove our technology’s commercial viability.”
Learn More: University of Minnesota